Illustrated is the amount of money which emerging therapeutic companies in the U.S. cardiovascular disease and disorders segment raised through initial public offerings from 2006 to 2023. In 2023, such companies in the U.S. raised 192 million dollars by going public.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Biotechnology Innovation Organization. (April 1, 2024). Amount raised through initial public offerings (IPOs) from cardiovascular disease companies in the U.S. from 2006 to 2023 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 29, 2026, from /statistics/597373/cardiovascular-companies-initial-public-offering-money-raised/
Biotechnology Innovation Organization. "Amount raised through initial public offerings (IPOs) from cardiovascular disease companies in the U.S. from 2006 to 2023 (in million U.S. dollars)." Chart. April 1, 2024. ÌÇÐÄÆƽâ°æ. Accessed July 29, 2026. /statistics/597373/cardiovascular-companies-initial-public-offering-money-raised/
Biotechnology Innovation Organization. (2024). Amount raised through initial public offerings (IPOs) from cardiovascular disease companies in the U.S. from 2006 to 2023 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 29, 2026. /statistics/597373/cardiovascular-companies-initial-public-offering-money-raised/
Biotechnology Innovation Organization. "Amount Raised through Initial Public Offerings (Ipos) from Cardiovascular Disease Companies in The U.S. from 2006 to 2023 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 1 Apr 2024, /statistics/597373/cardiovascular-companies-initial-public-offering-money-raised/
Biotechnology Innovation Organization, Amount raised through initial public offerings (IPOs) from cardiovascular disease companies in the U.S. from 2006 to 2023 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/597373/cardiovascular-companies-initial-public-offering-money-raised/ (last visited July 29, 2026)
Amount raised through initial public offerings (IPOs) from cardiovascular disease companies in the U.S. from 2006 to 2023 (in million U.S. dollars) [Graph], Biotechnology Innovation Organization, April 1, 2024. [Online]. Available: /statistics/597373/cardiovascular-companies-initial-public-offering-money-raised/
